Private Equity
Tools4Patient SA, a Belgian developer of tools to optimize and accelerate drug development programs, has raised $4.5 million in Series B financing. The investors included Innovation Fund, Sambrinvestm, Jean-Pierre Delwart, former CEO of Eurogentec and Jean Stephenne, former president of GlaxoSmithKline Biologicals.
1 min read · 16 May 2019
Tools4Patient SA, a Belgian developer of tools to optimize and accelerate drug development programs, has raised $4.5 million in Series B financing. The investors included Innovation Fund, Sambrinvestm, Jean-Pierre Delwart, former CEO of Eurogentec and Jean Stephenne, former president of GlaxoSmithKline Biologicals.
1 min read · 16 May 2019
San Francisco-based Wheelwell Inc, a social-commerce company for the automotive market, has raised $3 million in financing. James Currier of NFX Capital and Hans Tung of GGV Capital led the round.
1 min read · 16 May 2019
San Francisco-based Wheelwell Inc, a social-commerce company for the automotive market, has raised $3 million in financing. James Currier of NFX Capital and Hans Tung of GGV Capital led the round.
1 min read · 16 May 2019
San Francisco and Scottsdale-based Boomtown, which helps organizations that sell, activate and support business technology products, has raised $12 million in Series B funding. Telstra Ventures led the round with participation from Capital One Growth Ventures, Nyca Partners, Commerce Ventures, Spider Capital and NHN Ventures.
1 min read · 16 May 2019
San Francisco and Scottsdale-based Boomtown, which helps organizations that sell, activate and support business technology products, has raised $12 million in Series B funding. Telstra Ventures led the round with participation from Capital One Growth Ventures, Nyca Partners, Commerce Ventures, Spider Capital and NHN Ventures.
1 min read · 16 May 2019
New York City-based Prevail Therapeutics Inc, a gene therapy company, has promoted Dr. Yong Dai to chief technology officer. Also, the company has named Tim Adams to its board of directors as audit committee chair while Dr. Francois Nader, a member of the board, will expand his role as non-executive chairman. Prevail's backers include OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners LP, Boxer Capital LLC, Adage Capital Management LP and Alexandria Venture Investments.
4 min read · 16 May 2019
New York City-based Prevail Therapeutics Inc, a gene therapy company, has promoted Dr. Yong Dai to chief technology officer. Also, the company has named Tim Adams to its board of directors as audit committee chair while Dr. Francois Nader, a member of the board, will expand his role as non-executive chairman. Prevail's backers include OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners LP, Boxer Capital LLC, Adage Capital Management LP and Alexandria Venture Investments.
4 min read · 16 May 2019
Chicago-based The Small Exchange, a new futures exchange, has secured $10 million in funding. The investors were Citadel Securities and Jump Capital.
1 min read · 16 May 2019
Aeneas Capital and Pyrinas are launching a fund that will acquire and develop co-working space and incubator facilities for the life sciences sector in the United States. The target of Pyrinas US Healthcare Real Estate Fund 1 SP is $120 million.
3 min read · 16 May 2019
